Intercure Ltd.
Business
InterCure Ltd. produces, manufactures and distributes pharmaceutical-grade cannabis and cannabis-based products for medical use. Its main products include dried cannabis inflorescences and cannabis extracts in oil form, developed under IMC‑GMP and IMC‑GAP standards with defined cannabinoid profiles and branded families such as CANNDOC and Cookies. The company operates through subsidiaries and divisions including Canndoc, Cannolam, Leon Pharm, Pharmazone and a network of trade houses and pharmacies that manage cultivation, manufacturing, distribution and retail pharmacy operations. InterCure markets and distributes its products primarily in Israel and is establishing partnerships and distribution channels across the European Union, the United Kingdom, Austria, Germany, and Australia.
Summary from filing dated 2025-05-01
Financials
Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.
| Revenue | — |
| Net income | $-36.78M |
| Total assets | $690.55M |
| Total liabilities | $294.19M |
| Stockholders' equity | — |
| Operating cash flow | — |